Antimicrobial Stewardship Record
The tracked antibiotic utilization and intervention data including days of therapy, culture results, de-escalation opportunities, and pharmacist recommendations.
Why This Object Matters for AI
AI antimicrobial stewardship requires antibiotic usage linked to cultures; without stewardship data, AI cannot recommend appropriate de-escalation.
Pharmacy Operations Capacity Profile
Typical CMC levels for pharmacy operations in Healthcare organizations.
CMC Dimension Scenarios
What each CMC level looks like specifically for Antimicrobial Stewardship Record. Baseline level is highlighted.
Antimicrobial stewardship activities are not formally documented. Infectious disease pharmacists make verbal recommendations to prescribers about antibiotic de-escalation or therapy changes, but these interactions are not recorded. There is no organizational record of which patients received stewardship interventions, what was recommended, or what outcomes resulted from the recommendations.
None — AI cannot analyze antimicrobial utilization patterns, recommend de-escalation opportunities, or track stewardship outcomes because no formal antimicrobial stewardship records exist.
Create formal antimicrobial stewardship records — document each stewardship intervention including patient identifier, target antibiotic, culture results reviewed, recommendation made, prescriber response, and clinical outcome.
Antimicrobial stewardship interventions are logged in pharmacist notes within the EHR. Records note that a recommendation was made, but the documentation format varies by pharmacist. Some entries include culture results and de-escalation rationale; others simply state 'discussed antibiotic therapy with team.' Days of therapy calculations are tracked in aggregate spreadsheets separate from individual patient records.
AI can identify that stewardship interventions occurred from pharmacist notes, but cannot systematically analyze intervention types, recommendation acceptance rates, or clinical impact because records lack consistent structure for intervention details and outcomes.
Standardize antimicrobial stewardship documentation — implement structured records including target antibiotic, indication, culture organism and sensitivities, days of therapy, de-escalation opportunity type, specific recommendation, prescriber acceptance status, and clinical outcome tracking.
Antimicrobial stewardship records follow a standardized format: target antibiotic with coded drug identifier, clinical indication, culture organism with sensitivity pattern, days of therapy (DOT), de-escalation opportunity classification, specific pharmacist recommendation, prescriber response (accepted/modified/rejected), and outcome measures. Every stewardship intervention is documented consistently. But stewardship records are standalone documents — not linked to the institutional antibiogram, pharmacy formulary restrictions, or infection control surveillance records.
AI can analyze stewardship intervention patterns, calculate recommendation acceptance rates, and track DOT trends from standardized records. Cannot correlate interventions with institutional resistance patterns, formulary restriction effectiveness, or infection control outcomes because those connections are not documented.
Link stewardship records to institutional context — connect each intervention to the current antibiogram (local resistance patterns), formulary restriction protocols, infection control surveillance data, and patient clinical outcome records.
Antimicrobial stewardship records connect to institutional context. Each intervention links to the current antibiogram (showing local resistance rates for the target organism), formulary restriction criteria (showing whether the antibiotic requires stewardship approval), infection control surveillance (showing institutional infection trends), and patient clinical outcomes. A pharmacist can query 'show me all stewardship interventions for carbapenem de-escalation this quarter alongside institutional Pseudomonas resistance trends and patient outcomes.'
AI can perform comprehensive stewardship analysis — correlating intervention patterns with resistance trends, measuring formulary restriction impact on utilization, and assessing whether de-escalation recommendations align with institutional resistance patterns and produce favorable patient outcomes.
Implement formal stewardship entity schemas — model each stewardship record as a structured entity with typed relationships to patient medication profiles, culture results, antibiogram entries, formulary restrictions, and outcome measurements.
Antimicrobial stewardship records are schema-driven entities with full relational modeling. Each record links to patient medication profiles, microbiology culture results with sensitivities, antibiogram entries for the specific organism, formulary restriction protocols, infection control events, and clinical outcome measurements. An AI agent can navigate from any stewardship intervention to the complete clinical, microbiological, and institutional context.
AI can autonomously manage antimicrobial stewardship — identifying de-escalation opportunities from culture results and antibiogram patterns, generating patient-specific recommendations, monitoring stewardship program effectiveness, and predicting resistance trend implications.
Implement real-time stewardship intelligence streaming — publish every culture result, antibiotic order, stewardship intervention, and resistance pattern update as it occurs for continuous antimicrobial management intelligence.
Antimicrobial stewardship records are real-time intelligence streams. Every culture result, antibiotic prescribing event, stewardship intervention, resistance pattern update, and clinical outcome updates the stewardship profile continuously. The record reflects the live state of antimicrobial management across the institution, not a collection of individual intervention notes reviewed periodically.
Fully autonomous antimicrobial stewardship intelligence — continuously monitoring every prescribing, culture, resistance, and outcome signal in real-time, optimizing antibiotic management as a comprehensive stewardship engine.
Ceiling of the CMC framework for this dimension.
Capabilities That Depend on Antimicrobial Stewardship Record
Other Objects in Pharmacy Operations
Related business objects in the same function area.
Medication Record
EntityThe patient's comprehensive medication list including active prescriptions, historical medications, allergies, adverse reactions, and adherence patterns.
Pharmacy Formulary
EntityThe approved list of medications available for prescribing including formulary status, restrictions, therapeutic alternatives, and prior authorization requirements.
Controlled Substance Dispensing Record
EntityThe detailed transaction record of controlled substance withdrawals from automated dispensing cabinets including user, patient, quantity, waste, and witness.
IV Compounding Order
EntityThe pharmacy order for IV preparation including drug, concentration, diluent, volume, and beyond-use dating with verification steps and technician assignment.
Drug Shortage Record
EntityThe tracked record of drug shortages affecting the organization including shortage reason, duration, therapeutic alternatives, and conservation protocols.
Pharmacogenomic Profile
EntityThe patient's genetic test results relevant to drug metabolism including gene variants, metabolizer phenotypes, and actionable drug-gene interactions.
Medication Adherence Record
EntityThe tracked pattern of medication fills and refills including proportion of days covered, gaps in therapy, and intervention history.
Antibiogram
EntityThe institutional summary of antimicrobial susceptibility patterns showing local resistance rates by organism and antibiotic to guide empiric therapy.
What Can Your Organization Deploy?
Enter your context profile or request an assessment to see which capabilities your infrastructure supports.